Remote Breast Cancer Screening Study

Sponsor
The First Affiliated Hospital of the Fourth Military Medical University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04527510
Collaborator
(none)
30,000
2
47
15000
319.3

Study Details

Study Description

Brief Summary

A multi-center, prospective, cohort study to evaluate the efficiency of breast cancer screening based on Automated Breast Ultrasound (AB US) with remote reading mode.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Conventional-reading
  • Diagnostic Test: Second-reading
  • Diagnostic Test: Concurrent-reading
  • Diagnostic Test: Tow views-reading
  • Diagnostic Test: Handheld US-screening

Detailed Description

The burden of breast cancer incidence and mortality is rapidly growing during the past two decades in China. Screening has been proven to be effective in detecting early-stage disease and reducing mortality of 10% to 39% due to breast cancer. US is used as a primary screening method among Chinese women because Asian women characteristically have higher-density breasts than other ethnic groups. However, US is dependent on operator experience, lack of standardized scanning protocols, limited ultrasound physician and heavy workloads. In order to improve the efficiency and quality of breast cancer screening among Chinese women, a new remote screening pattern based on AB US was proposed and studied for breast cancer in China. This multi-center, prospective, cohort study aims to evaluate the efficiency of breast cancer screening based on AB US with remote reading mode. In addition, we will also explore the practice value of AI on AB US screening and efficient image acquiring and reading modes of AB US.

Study Design

Study Type:
Observational
Anticipated Enrollment :
30000 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Remote Breast Cancer Screening Based on Automated Breast Ultrasound Among Chinese Women: a Multi-center, Prospective, Cohort Study
Actual Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Aug 1, 2025
Anticipated Study Completion Date :
Aug 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Conventional-reading

Diagnostic Test: Conventional-reading
Two radiologists interpret at least three views of each breast without AI independently.

Second-reading

Diagnostic Test: Second-reading
One radiologist reads AB US images without AI first, then combines the indications of AI marks to make the final decision.

Concurrent-reading

Diagnostic Test: Concurrent-reading
One radiologist identifies CAD marks first, then quickly browses the entire AB US examination to make the final decision.

Tow-view-reading

Diagnostic Test: Tow views-reading
Two radiologists interpret only two views of each breast without AI independently.

Handheld US-screening

Diagnostic Test: Handheld US-screening
One radiologist screens the breast cancer using Handheld US and interprets images immediately.

Outcome Measures

Primary Outcome Measures

  1. The performance of breast cancer screening based on AB US with remote reading mode [4 years]

    The performance of breast cancer screening based on AB US with remote reading mode will be evaluated by cancer detection rate, recall rate, sensitivity, specificity, positive predictive value, early detection of breast cancer, interval cancers and time for image acquisition and interpretation.

Secondary Outcome Measures

  1. Evaluate the performance of AI on breast cancer screening based on AB US with remote reading mode [4 years]

    Evaluate the performance of AI on breast cancer screening based on AB US with remote reading mode (Conventional-reading vs. Second-reading / Concurrent-reading)

  2. Evaluate the performance of the image acquisition and interpretation modes in breast cancer screening based on AB US with remote reading mode [4 years]

    Evaluate the performance of the image acquisition and interpretation modes in breast cancer screening based on AB US with remote reading mode (two views vs. three views)

  3. Evaluate the performance of breast cancer screening according to the breast US device [4 years]

    Evaluate the performance of breast cancer screening according to the breast US device (Hand-held US vs. AB US)

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Any age at 35 and over

  2. Screening breast cancer with AB US

  3. Obtaining written informed consent

Exclusion Criteria:
  1. symptoms of breast cancer

  2. surgical of breast within 12 months prior to the study

  3. known diagnosis breast cancer

  4. poor image quality

  5. follow-up was less than 12 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 The First Affiliated Hospital of Fourth Military Medical University Xi'an Shaanxi China 710000
2 The First Affiliated Hospital of the Fourth Military Medical University Xi'an Shaanxi China

Sponsors and Collaborators

  • The First Affiliated Hospital of the Fourth Military Medical University

Investigators

  • Principal Investigator: Hongping Song, PHD,MD, Xijing hospital of The fourth military medical university

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Song Hongping, Principal Investigator, The First Affiliated Hospital of the Fourth Military Medical University
ClinicalTrials.gov Identifier:
NCT04527510
Other Study ID Numbers:
  • 2021LC2210
First Posted:
Aug 26, 2020
Last Update Posted:
Aug 17, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Song Hongping, Principal Investigator, The First Affiliated Hospital of the Fourth Military Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 17, 2022